27730215 | The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. | Sci Adv | 2016 Oct 7 | Law EK | - |
29140415 | APOBEC3A/B deletion polymorphism and cancer risk. | Carcinogenesis | 2018 Feb 9 | Gansmo LB | doi: 10.1093/carcin/bgx131. |
25750306 | APOBEC3B: a potential factor suppressing growth of human hepatocellular carcinoma cells. | Anticancer Res | 2015 Mar | Wu PF | - |
27044816 | APOBEC3B expression in drug resistant MCF-7 breast cancer cell lines. | Biomed Pharmacother | 2016 Apr | Onguru O | doi: 10.1016/j.biopha.2016.02.004 |
24154874 | APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. | Cancer Res | 2013 Dec 15 | Leonard B | doi: 10.1158/0008-5472.CAN-13-1753 |
26476745 | APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers. | Breast Cancer | 2016 Sep | Tsuboi M | doi: 10.1007/s12282-015-0641-8 |
26191203 | The roles of APOBEC3B in gastric cancer. | Int J Clin Exp Pathol | 2015 May 1 | Zhang J | - |
27155849 | Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation. | Tumour Biol | 2016 Sep | Revathidevi S | - |
23598277 | APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. | Cancer Res | 2013 Jun 15 | Nowarski R | doi: 10.1158/0008-5472.CAN-13-0728 |
26320772 | Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population. | J Cancer Res Clin Oncol | 2016 Jan | Ghler S | doi: 10.1007/s00432-015-2038-7 |
26682542 | Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer. | Hum Genomics | 2015 Dec 18 | Zhang Y | doi: 10.1186/s40246-015-0056-9. |
23599896 | DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. | Elife | 2013 Apr 16 | Taylor BJ | doi: 10.7554/eLife.00534. |
25401976 | FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis. | Oncotarget | 2015 Feb 20 | Waters CE | - |
24728294 | Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. | Nat Genet | 2014 May | Nik-Zainal S | doi: 10.1038/ng.2955 |
25123150 | Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers. | Horm Cancer | 2014 Dec | Sieuwerts AM | doi: 10.1007/s12672-014-0196-8 |
27977754 | Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women. | PLoS One | 2016 Dec 15 | Tokunaga E | doi: 10.1371/journal.pone.0168090 |
27552096 | The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer. | PLoS One | 2016 Aug 23 | Liu J | doi: 10.1371/journal.pone.0161731 |
28141868 | Progressive APOBEC3B mRNA expression in distant breast cancer metastases. | PLoS One | 2017 Jan 31 | Sieuwerts AM | doi: 10.1371/journal.pone.0171343 |
28977491 | p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells. | Nucleic Acids Res | 2017 Nov 2 | Periyasamy M | doi: 10.1093/nar/gkx721. |
28062980 | Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer. | Breast Cancer Res Treat | 2017 Feb | Radmanesh H | doi: 10.1007/s10549-016-4100-9 |
28825669 | Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression. | Viruses | 2017 Aug 21 | Warren CJ | doi: 10.3390/v9080233. |
30130388 | Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates. | ACS Chem Biol | 2018 Sep 21 | Liu M | doi: 10.1021/acschembio.8b00639 |
30457868 | Structural Analysis of the Active Site and DNA Binding of Human Cytidine Deaminase APOBEC3B. | J Chem Theory Comput | 2019 Jan 8 | Hou S | doi: 10.1021/acs.jctc.8b00545 |